pubmed semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Coadministered Cagrilintide and Semaglutide in

The GIP receptor agonism complements GLP-1 receptor activation by enhancing glucose-dependent insulin secretion, thereby improving glycemic control and weight loss more effectively than GLP-1RAs alone

It might be safe to use GLP-1 [receptor agonists] in the preoperative period, Qais AbuHasan , MD, research fellow at the Indiana University School of Medicine, who presented the findings, said in the release

Lilly does not promote or encourage use of any Lilly medicine outside of its FDA-approved indication. GLP-1 drugs and binge eating While some people with disordered eating over-restrict, others can binge to deal with stress or difficult emotions

Salman M

You then have to reassemble it intracellularly, which partially defeats the purpose of supplementing the completed molecule

That is an important clue